Open Access
Open access
Acta Pharmaceutica Sinica B, volume 11, issue 8, pages 2265-2285

Influencing factors and strategies of enhancing nanoparticles into tumors in vivo

Zhang Mingming 1
Gao Shan 1
Yang Dongjuan 1
Fang Yan 1
Lin Xiaojie 1
Jin Xuechao 1
LIU Yuli 1
Su Kexin 1
Shi Kai 1
Publication typeJournal Article
Publication date2021-08-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor14.5
ISSN22113835, 22113843
General Pharmacology, Toxicology and Pharmaceutics
Abstract
The administration of nanoparticles (NPs) first faces the challenges of evading renal filtration and clearance of reticuloendothelial system (RES). After that, NPs infiltrate through the expanded endothelial space and penetrated the dense stroma of tumor microenvironment to tumor cells. As long as possible to prolong the time of NPs remaining in tumor tissue, NPs release active agent and induce pharmacological action. This review provides a comprehensive summary of the physical and chemical properties of NPs and the influence of various biological factors in tumor microenvironment, and discusses how to improve the final efficacy through adjusting the characteristics and structure of NPs. Perspectives and future directions are also provided.

Citations by journals

2
4
6
8
10
Acta Pharmaceutica Sinica B
Acta Pharmaceutica Sinica B, 10, 10.99%
Acta Pharmaceutica Sinica B
10 publications, 10.99%
Pharmaceutics
Pharmaceutics, 5, 5.49%
Pharmaceutics
5 publications, 5.49%
Journal of Drug Delivery Science and Technology
Journal of Drug Delivery Science and Technology, 5, 5.49%
Journal of Drug Delivery Science and Technology
5 publications, 5.49%
International Journal of Nanomedicine
International Journal of Nanomedicine, 4, 4.4%
International Journal of Nanomedicine
4 publications, 4.4%
Nanomaterials
Nanomaterials, 3, 3.3%
Nanomaterials
3 publications, 3.3%
Molecules
Molecules, 3, 3.3%
Molecules
3 publications, 3.3%
Journal of Controlled Release
Journal of Controlled Release, 3, 3.3%
Journal of Controlled Release
3 publications, 3.3%
Biomedicine and Pharmacotherapy
Biomedicine and Pharmacotherapy, 3, 3.3%
Biomedicine and Pharmacotherapy
3 publications, 3.3%
Gels
Gels, 2, 2.2%
Gels
2 publications, 2.2%
Chinese Chemical Letters
Chinese Chemical Letters, 2, 2.2%
Chinese Chemical Letters
2 publications, 2.2%
Advanced Science
Advanced Science, 2, 2.2%
Advanced Science
2 publications, 2.2%
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2, 2.2%
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
2 publications, 2.2%
International Journal of Biological Macromolecules
International Journal of Biological Macromolecules, 2, 2.2%
International Journal of Biological Macromolecules
2 publications, 2.2%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 1.1%
International Journal of Molecular Sciences
1 publication, 1.1%
Cancers
Cancers, 1, 1.1%
Cancers
1 publication, 1.1%
Frontiers in Toxicology
Frontiers in Toxicology, 1, 1.1%
Frontiers in Toxicology
1 publication, 1.1%
Journal of Nanobiotechnology
Journal of Nanobiotechnology, 1, 1.1%
Journal of Nanobiotechnology
1 publication, 1.1%
Acta Pharmacologica Sinica
Acta Pharmacologica Sinica, 1, 1.1%
Acta Pharmacologica Sinica
1 publication, 1.1%
Journal of Industrial and Engineering Chemistry, 1, 1.1%
Journal of Industrial and Engineering Chemistry
1 publication, 1.1%
International Journal of Pharmaceutics
International Journal of Pharmaceutics, 1, 1.1%
International Journal of Pharmaceutics
1 publication, 1.1%
Colloids and Surfaces B: Biointerfaces
Colloids and Surfaces B: Biointerfaces, 1, 1.1%
Colloids and Surfaces B: Biointerfaces
1 publication, 1.1%
European Polymer Journal
European Polymer Journal, 1, 1.1%
European Polymer Journal
1 publication, 1.1%
Biochimica et Biophysica Acta - Reviews on Cancer
Biochimica et Biophysica Acta - Reviews on Cancer, 1, 1.1%
Biochimica et Biophysica Acta - Reviews on Cancer
1 publication, 1.1%
Pharmacology and Therapeutics
Pharmacology and Therapeutics, 1, 1.1%
Pharmacology and Therapeutics
1 publication, 1.1%
Advanced healthcare materials
Advanced healthcare materials, 1, 1.1%
Advanced healthcare materials
1 publication, 1.1%
Biomedical Materials & Devices
Biomedical Materials & Devices, 1, 1.1%
Biomedical Materials & Devices
1 publication, 1.1%
Current Cancer Drug Targets
Current Cancer Drug Targets, 1, 1.1%
Current Cancer Drug Targets
1 publication, 1.1%
Molecular Pharmaceutics
Molecular Pharmaceutics, 1, 1.1%
Molecular Pharmaceutics
1 publication, 1.1%
Drug Delivery
Drug Delivery, 1, 1.1%
Drug Delivery
1 publication, 1.1%
2
4
6
8
10

Citations by publishers

5
10
15
20
25
30
35
Elsevier
Elsevier, 35, 38.46%
Elsevier
35 publications, 38.46%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 16, 17.58%
Multidisciplinary Digital Publishing Institute (MDPI)
16 publications, 17.58%
Springer Nature
Springer Nature, 10, 10.99%
Springer Nature
10 publications, 10.99%
Wiley
Wiley, 7, 7.69%
Wiley
7 publications, 7.69%
American Chemical Society (ACS)
American Chemical Society (ACS), 6, 6.59%
American Chemical Society (ACS)
6 publications, 6.59%
Dove Medical Press
Dove Medical Press, 4, 4.4%
Dove Medical Press
4 publications, 4.4%
Frontiers Media S.A.
Frontiers Media S.A., 1, 1.1%
Frontiers Media S.A.
1 publication, 1.1%
Korean Society of Industrial Engineering Chemistry, 1, 1.1%
Korean Society of Industrial Engineering Chemistry
1 publication, 1.1%
Bentham Science
Bentham Science, 1, 1.1%
Bentham Science
1 publication, 1.1%
Taylor & Francis
Taylor & Francis, 1, 1.1%
Taylor & Francis
1 publication, 1.1%
Oxford University Press
Oxford University Press, 1, 1.1%
Oxford University Press
1 publication, 1.1%
IntechOpen, 1, 1.1%
IntechOpen
1 publication, 1.1%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 1.1%
Royal Society of Chemistry (RSC)
1 publication, 1.1%
5
10
15
20
25
30
35
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Zhang M. et al. Influencing factors and strategies of enhancing nanoparticles into tumors in vivo // Acta Pharmaceutica Sinica B. 2021. Vol. 11. No. 8. pp. 2265-2285.
GOST all authors (up to 50) Copy
Zhang M., Gao S., Yang D., Fang Y., Lin X., Jin X., LIU Y., Xiu Liu X. L., Su K., Shi K. Influencing factors and strategies of enhancing nanoparticles into tumors in vivo // Acta Pharmaceutica Sinica B. 2021. Vol. 11. No. 8. pp. 2265-2285.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.apsb.2021.03.033
UR - https://doi.org/10.1016%2Fj.apsb.2021.03.033
TI - Influencing factors and strategies of enhancing nanoparticles into tumors in vivo
T2 - Acta Pharmaceutica Sinica B
AU - Zhang, Mingming
AU - Gao, Shan
AU - Yang, Dongjuan
AU - Fang, Yan
AU - Lin, Xiaojie
AU - Jin, Xuechao
AU - LIU, Yuli
AU - Xiu Liu, Xiu Liu
AU - Su, Kexin
AU - Shi, Kai
PY - 2021
DA - 2021/08/01 00:00:00
PB - Elsevier
SP - 2265-2285
IS - 8
VL - 11
PMID - 34522587
SN - 2211-3835
SN - 2211-3843
ER -
BibTex |
Cite this
BibTex Copy
@article{2021_Zhang,
author = {Mingming Zhang and Shan Gao and Dongjuan Yang and Yan Fang and Xiaojie Lin and Xuechao Jin and Yuli LIU and Xiu Liu Xiu Liu and Kexin Su and Kai Shi},
title = {Influencing factors and strategies of enhancing nanoparticles into tumors in vivo},
journal = {Acta Pharmaceutica Sinica B},
year = {2021},
volume = {11},
publisher = {Elsevier},
month = {aug},
url = {https://doi.org/10.1016%2Fj.apsb.2021.03.033},
number = {8},
pages = {2265--2285},
doi = {10.1016/j.apsb.2021.03.033}
}
MLA
Cite this
MLA Copy
Zhang, Mingming, et al. “Influencing factors and strategies of enhancing nanoparticles into tumors in vivo.” Acta Pharmaceutica Sinica B, vol. 11, no. 8, Aug. 2021, pp. 2265-2285. https://doi.org/10.1016%2Fj.apsb.2021.03.033.
Found error?